Web notes  

April 2020

COVID-19 Funding Opportunities

The Office of the Vice Provost for Research (VPR) has compiled a list of funding opportunities specific to COVID-19. This list will be updated as new opportunities arise.

National Science Foundation (NSF) Partnerships for Innovation (PFI) Program

Internal deadline: May 19, 2020

The Partnerships for Innovation (PFI) Program within the Division of Industrial Innovation and Partnerships (IIP) offers researchers from all disciplines of science and engineering funded by NSF the opportunity to perform translational research and technology development, catalyze partnerships and accelerate the transition of discoveries from the laboratory to the marketplace for societal benefit. The Research Partnerships (PFI-RP) track seeks to support complex, multi-faceted technology development projects that are typically beyond the scope of a single researcher or institution and require a multi-organizational, interdisciplinary, synergistic collaboration. The estimated award amount is $550,000.

Webinars will be held to answer questions about the solicitation. Registration will be available on the NSF Partnerships for Innovation website (https://www.nsf.gov/PFI). Potential proposers and their partners are encouraged to attend.

Eligibility & Requirements:

  • PFI-RP proposals must include a co-PI who is a member or employee of the required Industrial Partner organization.
  • PIs with currently active PFI awards are requested to complete their then-current project before submitting a new PFI proposal.
  • A PI or co-PI may resubmit a proposal that was previously declined under a previous PFI solicitation or under a previous submission deadline in this solicitation;
  • The PFI-RP track requires the creation and implementation of new multidisciplinary, multi-organization partnerships between academia, industry and other public and private entities to pursue new innovative technology development projects.
  • A PI or co-PI may submit up to two (2) proposals each deadline: two (2) proposals to PFI-TT or one (1) proposal each to PFI-TT and PFI-RP.
  • NSF Lineage Requirement: All proposals submitted to the PFI program must meet a lineage requirement under one of the following two paths:
    (1) NSF-supported research results, or (2) NSF-supported customer discovery results through the NSF I-Corps Teams Program. The only allowed exception is for resubmission of PFI-RP proposals previously declined under solicitation NSF 18-511.
  • Resubmission of significantly improved revisions of a previously declined PFI proposal is strongly encouraged

Internal Nomination Process:
Interested applicants should submit the following documents:

  1. JHU Limited Submission Cover Sheet
  2. Proposal (maximum of two pages of text only, single spaced: 12-pt font and one-inch margins) (Note: figures, tables, and other reference material may be included in addition to the 2 pg. text limit)
  3. Curriculum Vitae of investigator, including current external research support and publications
  4. Budget (two pages maximum)

To apply, please visit: https://research.jhu.edu/rdt/ls-internal-application/. Questions? Comments? Email the Research Development Team at resapp@jhu.edu

1907 Trailblazer Award

Internal deadline: May 21, 2020

The 1907 Trailblazer Award was established to encourage high-impact, disruptive, step-change approaches to research in the brain and mind sciences for mental health. The purpose of the award is to promote these aims by providing a $100,000 research gift on an unrestricted basis, a $20,000 prize to enhance the economic security of the scientist, and travel & expense coverage for attendance at two annual meetings. Projects must be grounded in the study of biological mechanisms underlying brain function, cognitive processes, and/or consciousness. The award will support projects for basic science in addition to near-term applications (e.g. disruptive technologies and potential clinical interventions). The key criterion in assessing applications will be the extent to which research programs bring us closer to causes and cures based on an enhanced understanding of how aberrant neurobiological and/or psychological mechanisms give rise to behavioral (objective) and psychological (subjective) symptoms. Research programs that simply test the efficacy of an existing intervention or that follow established research paradigms (such as using standard analytic tools on large public imaging databases) are not suitable for this call.

Eligibility & Requirements:

  • Applicants must be within ten years of the date when PhD/MD degree was awarded.
  • Applicants must demonstrate independence from senior colleagues and must be able to initiate and direct their own research as principal investigator, have full responsibility for running their labs and full control of their research funds. Postdoctoral researchers working primarily in another investigator's research group, as well as adjunct faculty, are not eligible to apply.
  • Applicants must have a strong track record of scientific publications relevant to their research program Research applications may be related to but cannot be identical to any other currently funded projects

Internal Nomination Process:
Interested applicants should complete their application at the following link: https://jhu.infoready4.com/#competitionDetail/1811320

Requirements are listed below.

  1. Proposal: maximum of four pages of text addressing the following questions: What is the novel idea and what is the potential impact to the field? What is the scientific rationale of the idea given current gaps in knowledge? What is your execution plan and why are you uniquely positioned to execute? Why is 1907 Research best positioned to partner with you?
  2. Curriculum Vitae of investigator, including current external research support and publications
  3. Budget (two pages maximum)
  4. Letter of Recommendation from the Department Chair/Director

To apply, please visit: https://jhu.infoready4.com/#competitionDetail/1811320. Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.

The Hartwell Foundation Individual Biomedical Research Award Program (IBRA)

Internal deadline: June 2, 2020

Johns Hopkins University anticipates being named one of The Hartwell Foundation's Top Ten Centers of Biomedical Research for 2020 and, as such, eligible to participate in this year's competition for the Hartwell Individual Biomedical Research Award Program (IBRA). The Hartwell Foundation provides funding for transformative early stage, innovative and cutting-edge biomedical research that has not yet qualified for significant funding from outside sources, and that has the potential to benefit children of the United States. The Foundation anticipates awarding $100,000 per year for three years.

Dr. Marc Donohue, Professor of Chemical and Biomolecular Engineering and Director of the Johns Hopkins Hartwell Program along with current and former Hartwell Investigators on the JHU faculty, will host an information session via Zoom for the Hartwell IBRA competition:

Wednesday, May 13: 12:00-1:00PM
Zoom Link: https://wse.zoom.us/j/4105167761?pwd=VjltVlNyUStNMHBEQTlpUU1TTGpTdz09

Eligibility & Requirements:

  • Faculty members at any level are encouraged to apply
  • Nominees must be chosen from faculty and research staff drawn from appropriate areas of basic and applied life sciences, including engineering focused on biomedical applications.
  • The recipient should be a citizen of the United States or hold permanent residence, must hold a full-time appointment in the sponsoring institution, and must be eligible to serve as a principal investigator in biomedical research with their own dedicated lab space.
  • Must produce compelling justification that Hartwell support will be truly transformative to the career of the Nominee. i.e. Hartwell prefers to support assistant professors with no significant external funding.

Internal Nomination Process:
Interested applicants should complete their application at the following link by June 2, 2020: https://jhu.infoready4.com/#competitionDetail/1812163.

Requirements are listed below.

1. Pre-Proposal consisting of the following sections (2-3 pages TOTAL):

  • Title
  • Statement of Problem - description and magnitude of the problem in the United States; emphasize what makes it an important issue (e.g., prevalence, incidence, morbidity and mortality rates). Ignore economic considerations.
  • Compelling Interest - identify the unmet need and how addressing it successfully will provide a benefit for children of the United States.
  • Innovation - identify the novel idea(s), discovery, or creative insight that may inspire a distinctive shift in perspective, provide a strategic advantage or offer a translational benefit; identify relevant model test systems, important experiments and the technologic approach that will be used to construct or test hypotheses.
  • Justification for Funding - describe what will happen if the proposed research is successful (e.g. diagnosis, therapeutic intervention, prevention, clinical trials, etc.) and how successful outcomes will be deployed either translationally or strategically to benefit children.
  • Early State, Innovative & Cutting Edge Research - avoid the use of any obscure technical terms, acronyms, abbreviations, or nuanced jargon that are unlikely to be understood by a lay reader; explain explicitly in three separate paragraphs (2-3 sentences each) how the research is:
    • Early State - the first sentence must begin "My research is early-stage because…" Describe the early-stage nature of the proposed research, but not from the perspective that as a Nominee it is a new area of interest. Justify how the research may be pioneering and is not simply an incremental advancement or extension of existing research by the Nominee or others; discuss the origin and timing of any discovery or first recognition of the innovation (e.g., the date of first disclosure of intellectual property) or the date of acquisition of any preliminary data. Note: Preliminary data is not a prerequisite for funding consideration but may provide an indication of the early-stage nature of the research.
    • Innovative - the first sentence must begin "My research is innovative because…" Characterize how your proposed research is fundamentally new and original or represents a different approach that overcomes limitations compared to known competing approaches; and how if you are successful the outcome will generate a dynamic tactical advantage or create paradigm-shifting strategic value. Describe how your innovation(s) when clinically translated will provide a benefit and a practical solution that addresses an unmet need or will lead to a heretofore unrecognized benefit.
    • Cutting Edge - the first sentence must begin "My research is cutting-edge because…" Describe how the proposed research will utilize state-of-the-art technology and/or a ground-breaking approach that will promote success of the proposed research.

2. NIH or NSF-style Biosketch (no more than 5 pages)
3. Current and Pending Support (1page)

To apply, visit: https://jhu.infoready4.com/#competitionDetail/1812163. Questions? Comments? Email the Office of Foundation Relations at FoundationRelations@jhu.edu.

Michael J. Fox Foundation (MJFF) Challenge

No application deadline

The Michael J. Fox Foundation is sponsoring a $2 million prize to the first team to develop a viable selective alpha-synuclein PET tracer and agree to make that tracer available broadly.

The ability to image alpha-synuclein deposition in the brain would be a game-changing achievement for the Parkinson's disease (PD) field. The accumulation of aggregated alpha-synuclein is a pathological hallmark of PD and a priority target for drug development given its hypothesized contribution to neurodegeneration. In vivo imaging of alpha-synuclein pathology could be useful as a biomarker of the presence of disease and disease progression and as a pharmacodynamic tool for drug development. With this prize, the Foundation seeks to attract research teams and accelerate momentum to speed the development of such a tracer.

Contestants: Anyone is eligible for the prize who agrees to all contest rules. Contestants may be MJFF funded or not and can be from either academia or industry.

Contest rules:

  1. Contestants must apply for the prize with pre-clinical and clinical data supporting the broad use of their alpha-synuclein radiotracer. Judges may ask for additional data, including but not limited to raw imaging data.
  2. NOTE: All contestants must agree to make the winning radiotracer available for use by The Michael J. Fox Foundation and MJFF awardees through a nonexclusive license or other MJFF-approved mechanism.

Criteria for winning: The winning contestant must demonstrate that the radiotracer binds with relatively high selectivity to alpha-synuclein according to pre-specified criteria and must demonstrate proof-of-concept in human subjects, including people with Parkinson's disease and/or another synucleinopathy. See below for more details on submission requirements.

Timeline: There is no deadline for submissions. The $2 million award will be issued to the first contestant who submits compelling evidence of a viable selective tracer and agrees to its widespread use. If no award is given by mid-2018, The Michael J. Fox Foundation will evaluate the state of the field and utility of such a prize.

Return to top of Funding Opportunities

April 2020 articles:
Essential Information for Human Subjects Research Teams Related to COVID-19
Coronavirus Research Billing Notices and FAQ
Research Billing Buzz eNewsletter
Managing Investigational Product Returns from Research Participants
Update to Organization Policy on Registration of Clinical Trials
Changes in HSR Recertification
Update on Insurance and Research Participant Financial Responsibility Information Sheet: Signature No Longer Required
Change in JHM IRB Review Fees for Commercially-Funded Studies
Data and Safety Monitoring Board Training Manual Now Available
Good Clinical Practice (GCP) Fundamentals: Understanding and Applying GCP to Human Subject Research
Fee Schedule Adjustment for Hospital Services Charged to Clinical Trial Budgets
Changes to NIH-funded Human Subjects Research
Free Resources for Longitudinal Clinical Research Studies
JHM IRB Reliance Requests
Sharing Partnership for Innovative Research in Translation
Johns Hopkins Institute for Clinical and Translational Research
Johns Hopkins Clinical Research Network
Visit Animal Care and Use Committee Website
Current Classes
"Interinstitutional Assurance" Agreement
Health, Safety, and Environment (HSE) presents: Safety in Research Updates
COVID-19 Funding Opportunities
William T. Grant Scholars Program
Pew Biomedical Scholars Program
Michael J. Fox Foundation (MJFF) Challenge
COVID-19 and Research Updates
New System to Request Outgoing Subawards
Point of Contact for NIH Loan Repayment Program
JHU SOM Update on NIH Policy on Foreign Involvement
Disclosure of Payments from Foreign Educational Institutions and Government Agencies
Institutional Letter of Support Required for Institutional Training Grant Applications
Notice to the Johns Hopkins Community Regarding the National Science Foundation Grant Reporting Requirement for Harassment Findings and Actions
Prohibited Mention of Prior Review for New Replacement Applications
NIH Policy on Foreign Component Involvement
NIH Policy: Foreign Components Added to a Grant to a Domestic or Foreign Organization
Why Project Outcomes Matter in your Interim and Final Research Performance Progress Report (RPPR)
NIH Matchmaker, A Tool For Finding Similar NIH Projects
NIH Video Tutorials on How to Apply for Grants

This Month's Departmental Listings

Upcoming Deadlines for April, May and June

Temporary Closures and Updates at the Genetics Research Core Facilities


JHM AppointmentsEmployment @ JHM | Finding a Doctor | Disclaimer | Maps & Directions | Contact JHM 


                                                                                                                                                           The Web Center